| Literature DB >> 25984091 |
Kunio Kawanishi1, Takashi Takei1, Chiari Kojima1, Takahito Moriyama1, Hidekazu Sugiura1, Mitsuyo Itabashi1, Misao Tsukada1, Keiko Uchida1, Kazuho Honda2, Kosaku Nitta1.
Abstract
Oligomeganephronia is classified as a subgroup of renal hypoplasia, characterized by histopathologic abnormalities which progress to end-stage renal disease (ESRD) by school age. We describe three adult cases of oligomeganephronia who have not yet developed ESRD. We performed a renal biopsy in all of them. The pathological features, consisting of a reduced number of enlarged glomeruli, were diagnostic of oligomeganephronia. It was assumed that the condition had not progressed to ESRD in the patients because the degree of loss of glomeruli may have been milder than that in typical cases of oligomeganephronia.Entities:
Keywords: late-onset; low birth weight; oligomeganephronia; renal hypoplasia
Year: 2010 PMID: 25984091 PMCID: PMC4421621 DOI: 10.1093/ndtplus/sfq175
Source DB: PubMed Journal: NDT Plus ISSN: 1753-0784
Clinical and pathological findings in late-onset oligomeganephronia
| Case 1 | Case 2 | Case 3 | |
|---|---|---|---|
| Age/sex | 36/male | 19/female | 21/male |
| Past history | Taken care in NICU | ||
| Family history | Father, ESRD; sister, MPGN | ||
| Gestation (weeks)/birth weight (g) | 37/2700 (median) | 41/2410 (light for date) | 41/3405 (median) |
| Body mass index (kg/m2) | 20.9 | 21.8 | 19.1 |
| Initiation | Hypertension at medical check-up | Proteinuria at school urinalysis | Proteinuria at school urinalysis |
| Initial→recent blood pressure (mmHg) | 166/113→110/70 | 98/60→96/60 | 132/70→110/70 |
| Urinalysis | No proteinuria or haematuria | Proteinuria (1 +), RBC 1/1–4 HPF | Proteinuria (3 +), no haematuria |
| 24-h urine protein (g)/urine volume (mL/day) | 0.18/1800 | 0.53/1090 | 0.65/1810 |
| Initial/recent serum creatinine (mg/dL) | 2.65/2.89 | 1.14/1.20 | 1.20/1.12 |
| Echo findings (right; left mm) | Atrophic (89 × 41; 93 × 47), high echogenicity | Atrophic (87 × 29; 80 × 47), high echogenicity | Normal (106 × 45; 105 × 42) |
| Medication | ACEI, ARB, CCB, αβ-blocker, aspirin | ACEI, ARB, dilazep | ARB |
| Follow-up at our centre (years) | 3.5 | 3 | 1.5 |
| Pathologic findings | |||
| Glomerular number | 1.29 | 0.76 | 0.97 |
| Maximum of glomerular diameter | 200 | 310 | 270 |
| Number of glomerular sclerosis (/total) | 2/10 | 1/4 | 0/6 |
| Focal segmental glomerulosclerosis | (perihilar type) | ||
| Tubular atrophy and fibrosis (% of cortex) | 2.96 | 9.36 | 10.1 |
| Fluorescence staining | Non-specific IgM deposition | Non-specific IgM deposition | Non-specific IgM deposition |
| Electron microscopic examination | Partial foot process fusion | Partial foot process fusion | Almost normal |
NICU, neonatal intensive care unit; ESRD, end-stage renal disease.
Normal glomerular number (mean ± SD): 3.2 ± 1.2/mm2.
Normal glomerular diameter (mean ± SD): 201 ± 28 μm.
Fig. 1Renal biopsy showed a low number of enlarged glomeruli indicating oligomeganephronia. Light microscopy of biopsy specimens stained with periodic acid–Schiff (× 400). (A) Case 1. (B) Case 2. (C) Case 3.